1. Home
  2. VNRX vs CLGN Comparison

VNRX vs CLGN Comparison

Compare VNRX & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VolitionRX Limited

VNRX

VolitionRX Limited

HOLD

Current Price

$0.28

Market Cap

38.2M

Sector

Health Care

ML Signal

HOLD

Logo CollPlant Biotechnologies Ltd

CLGN

CollPlant Biotechnologies Ltd

HOLD

Current Price

$1.80

Market Cap

33.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VNRX
CLGN
Founded
N/A
2004
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Industrial Specialties
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.2M
33.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
VNRX
CLGN
Price
$0.28
$1.80
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
2
Target Price
$3.17
$11.50
AVG Volume (30 Days)
2.6M
16.9K
Earning Date
11-13-2025
11-26-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,472,007.00
$2,475,000.00
Revenue This Year
$55.33
$1,617.28
Revenue Next Year
$493.79
$83.54
P/E Ratio
N/A
N/A
Revenue Growth
14.48
280.77
52 Week Low
$0.27
$1.31
52 Week High
$0.94
$4.98

Technical Indicators

Market Signals
Indicator
VNRX
CLGN
Relative Strength Index (RSI) 32.86 36.71
Support Level $0.28 $1.77
Resistance Level $0.34 $2.08
Average True Range (ATR) 0.03 0.15
MACD 0.00 -0.02
Stochastic Oscillator 11.30 16.67

Price Performance

Historical Comparison
VNRX
CLGN

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

About CLGN CollPlant Biotechnologies Ltd

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.

Share on Social Networks: